|

Omeprazole Clinical Trials

3 actively recruiting trials across 2 locations

No change since August 2026

Also known as: Prilosec

Pipeline

Phase 1: 2Phase 3: 1

Top Sponsors

  • Murdoch Childrens Research Institute1
  • Hoffmann-La Roche1
  • Gilead Sciences1

Indications

  • Cancer2
  • Weight Management1
  • Diabetes1
  • Hodgkin Lymphoma1
  • Non-hodgkin Lymphoma1

Other1 trial

A Study Investigating the Change in Metabolism Phenotype in Paediatric, Adolescent & Young Adults With Hodgkin or Non-Hodgkin Lymphoma.
Phase 1

Greenbrae, California1 trial

A Study Evaluating the Efficacy and Safety of Inavolisib Plus Fulvestrant Compared With Alpelisib Plus Fulvestrant in Participants With HR-Positive, HER2-Negative, PIK3CA Mutated, Locally Advanced or Metastatic Breast Cancer Post CDK4/6i and Endocrine Combination Therapy

Marin Cancer Care Inc

Phase 3

Miami, Florida1 trial

Study of GS-4571 in Healthy Participants, Nondiabetic Obese Participants, and Nonobese Participants With Type 2 Diabetes Mellitus (T2DM)

Qps-Mra, Llc.

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.